Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

N Nagy, H Legendre, O Engels, S André… - … Journal of the …, 2003 - Wiley Online Library
BACKGROUND Knowledge of the expression of the galectins in human colon carcinomas is
mainly restricted to galectin‐3 and, to a lesser extent, galectin‐1. The current study analyzed …

[PDF][PDF] Refined Prognostic Evaluation in Colon Carcinoma Using Immunohistochemical Galectin Fingerprinting

N Nagy, H Legendre, O Engels, S André, H Kaltner… - CANCER, 2003 - academia.edu
BACKGROUND. Knowledge of the expression of the galectins in human colon carcinomas
is mainly restricted to galectin-3 and, to a lesser extent, galectin-1. The current study …

Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

N Nagy, H Legendre, O Engels, S Andre… - …, 2003 - weizmann.elsevierpure.com
BACKGROUND. Knowledge of the expression of the galectins in human colon carcinomas
is mainly restricted to galectin-3 and, to a lesser extent, galectin-1. The current study …

[引用][C] Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

N NAGY, H LEGENDRE, I SALMON, R KISS… - Cancer, 2003 - pascal-francis.inist.fr
Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin
fingerprinting CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic …

Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

N Nagy, H Legendre, O Engels, S Andre… - …, 2003 - weizmann.esploro.exlibrisgroup.com
BACKGROUND. Knowledge of the expression of the galectins in human colon carcinomas
is mainly restricted to galectin-3 and, to a lesser extent, galectin-1. The current study …

[引用][C] Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.

N Nagy, H Legendre, O Engels, S André, H Kaltner… - Cancer, 2003 - difusion.ulb.ac.be

Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting.

N Nagy, H Legendre, O Engels, S André, H Kaltner… - Cancer, 2003 - europepmc.org
Background Knowledge of the expression of the galectins in human colon carcinomas is
mainly restricted to galectin-3 and, to a lesser extent, galectin-1. The current study analyzed …

Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

N Nagy, H Legendre, O Engels, S André… - Cancer, 2003 - pubmed.ncbi.nlm.nih.gov
Background Knowledge of the expression of the galectins in human colon carcinomas is
mainly restricted to galectin-3 and, to a lesser extent, galectin-1. The current study analyzed …

[引用][C] Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

N Nagy, H Legendre, O Engels, S André, H Kaltner… - Cancer, 2003 - cir.nii.ac.jp

Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting

N Nagy, H Legendre, O Engels, S Andre… - …, 2003 - … .esploro.exlibrisgroup.com
BACKGROUND. Knowledge of the expression of the galectins in human colon carcinomas
is mainly restricted to galectin-3 and, to a lesser extent, galectin-1. The current study …